Valbiotis SA (EPA:ALVAL)
France
· Delayed Price · Currency is EUR 1.016
+0.054 (5.61%)
Mar 4, 2026, 5:26 PM CET
Valbiotis Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 0.91 | 0.18 | 4.73 | 0.79 | 0.3 | Upgrade
|
| Other Revenue | 0.14 | 0 | - | - | - | Upgrade
|
| Revenue | 1.05 | 0.18 | 4.73 | 0.79 | 0.3 | Upgrade
|
| Revenue Growth (YoY) | 494.32% | -96.28% | 502.93% | 163.42% | -90.36% | Upgrade
|
| Cost of Revenue | 2.07 | 2.34 | 2.04 | - | - | Upgrade
|
| Gross Profit | -1.03 | -2.16 | 2.69 | 0.79 | 0.3 | Upgrade
|
| Selling, General & Admin | 7.24 | 7.46 | 4.18 | 3.35 | 2.62 | Upgrade
|
| Research & Development | 0.92 | 4.64 | 7.15 | 9.1 | 7.03 | Upgrade
|
| Other Operating Expenses | - | -4.47 | -2.08 | -2.03 | -2.4 | Upgrade
|
| Operating Expenses | 8.47 | 8.26 | 9.85 | 12.77 | 8.7 | Upgrade
|
| Operating Income | -9.49 | -10.43 | -7.16 | -11.99 | -8.41 | Upgrade
|
| Interest Expense | - | -0.23 | -0.19 | -0.23 | -0.23 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.08 | 0.66 | - | -0.06 | 0.02 | Upgrade
|
| EBT Excluding Unusual Items | -9.42 | -9.99 | -7.35 | -12.27 | -8.61 | Upgrade
|
| Other Unusual Items | - | 0 | -0.02 | -0.04 | -0.07 | Upgrade
|
| Pretax Income | -9.42 | -9.99 | -7.37 | -12.31 | -8.68 | Upgrade
|
| Income Tax Expense | 0 | 0.03 | - | -0 | - | Upgrade
|
| Net Income | -9.42 | -10.03 | -7.37 | -12.31 | -8.68 | Upgrade
|
| Net Income to Common | -9.42 | -10.03 | -7.37 | -12.31 | -8.68 | Upgrade
|
| Shares Outstanding (Basic) | - | 16 | 12 | 10 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | - | 16 | 12 | 10 | 9 | Upgrade
|
| Shares Change (YoY) | - | 26.74% | 23.21% | 10.45% | 22.88% | Upgrade
|
| EPS (Basic) | - | -0.63 | -0.59 | -1.22 | -0.95 | Upgrade
|
| EPS (Diluted) | - | -0.63 | -0.59 | -1.22 | -0.95 | Upgrade
|
| Free Cash Flow | -8.04 | -11.68 | -8.08 | -9.3 | -7.46 | Upgrade
|
| Free Cash Flow Per Share | - | -0.74 | -0.65 | -0.92 | -0.81 | Upgrade
|
| Gross Margin | -97.99% | - | 56.81% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -907.65% | -5923.86% | -151.28% | -1526.88% | -2820.80% | Upgrade
|
| Profit Margin | -900.29% | -5696.02% | -155.67% | -1568.41% | -2913.09% | Upgrade
|
| Free Cash Flow Margin | -768.45% | -6638.64% | -170.78% | -1185.10% | -2504.03% | Upgrade
|
| EBITDA | -9.38 | -10.31 | -6.42 | -11.13 | -7.47 | Upgrade
|
| EBITDA Margin | - | - | -135.73% | - | - | Upgrade
|
| D&A For EBITDA | 0.11 | 0.11 | 0.74 | 0.85 | 0.94 | Upgrade
|
| EBIT | -9.49 | -10.43 | -7.16 | -11.99 | -8.41 | Upgrade
|
| EBIT Margin | - | - | -151.28% | - | - | Upgrade
|
| Revenue as Reported | 1.05 | 4.64 | 6.81 | 2.81 | 2.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.